LECTURE: New Data on ATTR-CM for Health Care Providers From CARDIO-TTRansform Join an AstraZeneca- and Ionis-sponsored session presenting phase 3 trial results for an investigational treatment for transthyretin amyloid cardiomyopathy (ATTR- CM).